291 related articles for article (PubMed ID: 12631363)
1. Proteinuria and the risk of developing end-stage renal disease.
Iseki K; Ikemiya Y; Iseki C; Takishita S
Kidney Int; 2003 Apr; 63(4):1468-74. PubMed ID: 12631363
[TBL] [Abstract][Full Text] [Related]
2. Relationship between predicted creatinine clearance and proteinuria and the risk of developing ESRD in Okinawa, Japan.
Iseki K; Kinjo K; Iseki C; Takishita S
Am J Kidney Dis; 2004 Nov; 44(5):806-14. PubMed ID: 15492946
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of high fasting plasma glucose and risk of developing end-stage renal disease in screened subjects in Okinawa, Japan.
Iseki K; Ikemiya Y; Kinjo K; Iseki C; Takishita S
Clin Exp Nephrol; 2004 Sep; 8(3):250-6. PubMed ID: 15480903
[TBL] [Abstract][Full Text] [Related]
4. Risk of developing end-stage renal disease in a cohort of mass screening.
Iseki K; Iseki C; Ikemiya Y; Fukiyama K
Kidney Int; 1996 Mar; 49(3):800-5. PubMed ID: 8648923
[TBL] [Abstract][Full Text] [Related]
5. Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort.
Iseki K; Ikemiya Y; Inoue T; Iseki C; Kinjo K; Takishita S
Am J Kidney Dis; 2004 Oct; 44(4):642-50. PubMed ID: 15384015
[TBL] [Abstract][Full Text] [Related]
6. Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the multiple risk factor intervention trial.
Ishani A; Grandits GA; Grimm RH; Svendsen KH; Collins AJ; Prineas RJ; Neaton JD
J Am Soc Nephrol; 2006 May; 17(5):1444-52. PubMed ID: 16611715
[TBL] [Abstract][Full Text] [Related]
7. Haematocrit and the risk of developing end-stage renal disease.
Iseki K; Ikemiya Y; Iseki C; Takishita S
Nephrol Dial Transplant; 2003 May; 18(5):899-905. PubMed ID: 12686662
[TBL] [Abstract][Full Text] [Related]
8. Influence of smoking and obesity on the development of proteinuria.
Tozawa M; Iseki K; Iseki C; Oshiro S; Ikemiya Y; Takishita S
Kidney Int; 2002 Sep; 62(3):956-62. PubMed ID: 12164878
[TBL] [Abstract][Full Text] [Related]
9. Body mass index and the risk of development of end-stage renal disease in a screened cohort.
Iseki K; Ikemiya Y; Kinjo K; Inoue T; Iseki C; Takishita S
Kidney Int; 2004 May; 65(5):1870-6. PubMed ID: 15086929
[TBL] [Abstract][Full Text] [Related]
10. Observation period for changes in proteinuria and risk prediction of end-stage renal disease in general population.
Usui T; Kanda E; Iseki C; Iseki K; Kashihara N; Nangaku M
Nephrology (Carlton); 2018 Sep; 23(9):821-829. PubMed ID: 28635004
[TBL] [Abstract][Full Text] [Related]
11. Risk of developing low glomerular filtration rate or elevated serum creatinine in a screened cohort in Okinawa, Japan.
Iseki K; Iseki C; Ikemiya Y; Kinjo K; Takishita S
Hypertens Res; 2007 Feb; 30(2):167-74. PubMed ID: 17460387
[TBL] [Abstract][Full Text] [Related]
12. Relationship between dyslipidemia and the risk of developing end-stage renal disease in a screened cohort.
Iseki K; Tozawa M; Ikemiya Y; Kinjo K; Iseki C; Takishita S
Clin Exp Nephrol; 2005 Mar; 9(1):46-52. PubMed ID: 15830273
[TBL] [Abstract][Full Text] [Related]
13. Proteinuria and decreased body mass index as a significant risk factor in developing end-stage renal disease.
Iseki K; Tokashiki K; Iseki C; Kohagura K; Kinjo K; Takishita S
Clin Exp Nephrol; 2008 Oct; 12(5):363-369. PubMed ID: 18584288
[TBL] [Abstract][Full Text] [Related]
14. Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease.
Hsu CY; McCulloch CE; Darbinian J; Go AS; Iribarren C
Arch Intern Med; 2005 Apr; 165(8):923-8. PubMed ID: 15851645
[TBL] [Abstract][Full Text] [Related]
15. Predictors of end-stage renal disease and body mass index in a screened cohort.
Iseki K; Ikemiya Y; Fukiyama K
Kidney Int Suppl; 1997 Dec; 63():S169-70. PubMed ID: 9407450
[TBL] [Abstract][Full Text] [Related]
16. The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL study.
Keane WF; Brenner BM; de Zeeuw D; Grunfeld JP; McGill J; Mitch WE; Ribeiro AB; Shahinfar S; Simpson RL; Snapinn SM; Toto R;
Kidney Int; 2003 Apr; 63(4):1499-507. PubMed ID: 12631367
[TBL] [Abstract][Full Text] [Related]
17. Persistent asymptomatic isolated microscopic hematuria in Israeli adolescents and young adults and risk for end-stage renal disease.
Vivante A; Afek A; Frenkel-Nir Y; Tzur D; Farfel A; Golan E; Chaiter Y; Shohat T; Skorecki K; Calderon-Margalit R
JAMA; 2011 Aug; 306(7):729-36. PubMed ID: 21846854
[TBL] [Abstract][Full Text] [Related]
18. Predictors in adolescence of ESRD in middle-aged men.
Sundin PO; Udumyan R; Sjöström P; Montgomery S
Am J Kidney Dis; 2014 Nov; 64(5):723-9. PubMed ID: 25124945
[TBL] [Abstract][Full Text] [Related]
19. Predictors of diabetic end-stage renal disease in Japan.
Iseki K
Nephrology (Carlton); 2005 Oct; 10 Suppl():S2-6. PubMed ID: 16174282
[TBL] [Abstract][Full Text] [Related]
20. Blood pressure and risk of end-stage renal disease in a screened cohort.
Iseki K; Ikemiya Y; Fukiyama K
Kidney Int Suppl; 1996 Jun; 55():S69-71. PubMed ID: 8743514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
